DocuSign recently introduced an AI-powered contract review assistant built on its Intelligent Agreement Management platform, while also reporting past-quarter and full-year results, updating revenue guidance, completing a large share repurchase program, and filing a US$564.32 million shelf registration related to employee stock offerings.
The AI assistant’s ability to automatically flag risky terms, draft playbooks, and integrate across legal, sales, and HR workflows highlights DocuSign’s push to turn agreement management into a broader productivity platform rather than a stand-alone eSignature tool.
Now we will examine how this AI-driven contract review launch and broader IAM push could influence DocuSign’s existing investment narrative.
Rare earth metals are the new gold rush. Find out which 25 stocks are leading the charge.
To own DocuSign, you need to believe it can shift from a mature eSignature product to a broader AI-first agreement platform, even as guidance points to more modest revenue growth. The new AI contract review assistant and IAM integrations speak directly to that pivot, but they do not remove the near term risk that upselling existing customers into IAM may be slower or less lucrative than hoped, especially with analysts already highlighting decelerating growth.
Among the recent announcements, the updated revenue guidance for the quarter ending April 30, 2026 (US$822 million to US$826 million) and full year 2027 (US$3,484 million to US$3,496 million) is most relevant here. It frames expectations around a more measured growth path just as DocuSign leans harder into AI-powered IAM, making the pace of adoption for products like the new contract review assistant an important swing factor for how this guidance is interpreted over time.
Yet even as DocuSign expands AI features and integrations, investors should be aware that slower than expected IAM adoption could…
Read the full narrative on DocuSign (it’s free!)
DocuSign’s narrative projects $3.8 billion revenue and $359.8 million earnings by 2028. This requires 7.3% yearly revenue growth and about a $78.8 million earnings increase from $281.0 million today.
Uncover how DocuSign’s forecasts yield a $78.28 fair value, a 66% upside to its current price.
DOCU 1-Year Stock Price Chart
The lowest estimate analysts paint a much tougher picture for you, assuming revenue of about US$3.6 billion and earnings near US$246 million by 2028, which contrasts sharply with the more optimistic IAM driven upside and shows how views on DocuSign’s AI opportunity and competitive pressures can differ widely and may shift again after this contract review announcement.
Explore 7 other fair value estimates on DocuSign – why the stock might be worth over 2x more than the current price!
Don’t just follow the ticker – dig into the data and build a conviction that’s truly your own.
A great starting point for your DocuSign research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
Our free DocuSign research report provides a comprehensive fundamental analysis summarized in a single visual – the Snowflake – making it easy to evaluate DocuSign’s overall financial health at a glance.
These stocks are moving-our analysis flagged them today. Act fast before the price catches up:
Outshine the giants: these 21 early-stage AI stocks could fund your retirement.
Capitalize on the AI infrastructure supercycle with our selection of the 35 best ‘picks and shovels’ of the AI gold rush converting record-breaking demand into massive cash flow.
Find 63 companies with promising cash flow potential yet trading below their fair value.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
Companies discussed in this article include DOCU.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com